Excellent outcomes reported for first targeted therapy for pediatric Hodgkin lymphoma
Scientists are reporting results of the first frontline clinical trial to use targeted therapy to tr...
Aggressive intervention recommended to prevent pediatric diabetes
Type 2 diabetes, once considered an adult disease,...
Study on impact of COVID-19 on pediatric mental health released
In March and April 2020, mental health claim lines...
Vimpat (lacosamide) Now Approved by FDA for Primary Generalized Tonic-Clonic Seizures and Expanded Pediatric Use for People Living with Epilepsy
ATLANTA, Nov. 17, 2020 /PRNewswire/ — UCB, a...
Number, Proportion of Pediatric COVID-19 Cases Rising in the U.S.
THURSDAY, Oct. 1, 2020 — Pediatric COVID-19 ...
High antiviral antibody levels may herald pediatric COVID-19 complication
Measuring blood antibody levels against SARS-CoV-2...
Study shows uptick in at-home pediatric fractures during COVID-19 pandemic
COVID-19 social distancing measures, including the...
Recommendations issued for pediatric abuse-related head trauma
(HealthDay)—In an American Academy of Pediatrics...
Study examines why colon cancer is more deadly in pediatric and young adult patients
Colon cancer is more likely to be lethal in childr...
BRAF inhibitor shows promising results in pediatric patients with low-grade glioma
Dabrafenib (Tafinlar), a BRAF inhibitor approved t...
